Literature DB >> 9328301

Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease.

J J Kril1, R F Butterworth.   

Abstract

Formalin-fixed sections from the brains of 36 patients (30 alcoholic and 6 nonalcoholic) with autopsy-proven cirrhosis who died while in a hepatic coma were stained with hematoxylin and eosin, and examined for the presence of diencephalic, cerebellar, pontine, and basal ganglia lesions. Significant neuropathology was identified in 23 of 36 cases consisting of mammillary body and thalamic lesions characteristic of Wernicke encephalopathy (WE) (9 cases, all alcoholic patients) and cerebellar degeneration (20 cases, 17 alcoholic and 3 nonalcoholic patients). Clinical diagnosis of WE had been entertained during life in only 2 of these patients. All cases, alcoholic and nonalcoholic, manifested mild to severe Alzheimer's type II astrocytosis. No cases of central pontine myelinolysis nor acquired (non-Wilsonian) hepatocerebral degeneration were found. These findings show that the brains of a high proportion of cirrhotic patients with end-stage liver disease manifest concomitant unsuspected diencephalic and cerebellar pathology. The high incidence of WE underscores the need for early sustained treatment of alcoholic cirrhotic patients with vitamin B1. Evaluation of the neurological sequelae of liver transplantation, particularly of alcoholic patients with end-stage liver disease, may require a careful neurological and radiological assessment both before and after surgery.

Entities:  

Mesh:

Year:  1997        PMID: 9328301     DOI: 10.1002/hep.510260405

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  35 in total

Review 1.  Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy.

Authors:  Laurent Spahr; Pierre R Burkhard; Hannelore Grötzsch; Antoine Hadengue
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Liver: risk of falls in cirrhosis predicted by psychometric testing.

Authors:  Roger F Butterworth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

3.  Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Christine M Schubert; Douglas M Heuman; James B Wade; Douglas P Gibson; Allyne Topaz; Kia Saeian; Muhammad Hafeezullah; Debulon E Bell; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Melanie B White; Arun J Sanyal
Journal:  Gastroenterology       Date:  2010-02-20       Impact factor: 22.682

Review 4.  Neuronal cell death in hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 5.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 6.  Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2015-02-19

Review 7.  Neurological complications post-liver transplantation: impact of nutritional status.

Authors:  Chantal Bemeur
Journal:  Metab Brain Dis       Date:  2012-11-06       Impact factor: 3.584

Review 8.  Challenges in diagnosing hepatic encephalopathy.

Authors:  K Weissenborn
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

Review 9.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

Review 10.  Encephalopathy and liver transplantation.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2012-11-16       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.